188Re-Listeria monocytogenes radiotherapeutic (Albert Einstein College of Medicine)

N/A

Report date: 2025/01/26 15:39:18

Base Information

Drug Name188Re-Listeria monocytogenes radiotherapeutic (Albert Einstein College of Medicine)
Drug Alias Name188Rhenium-Listeria monocytogenes radiotherapeutic (Albert Einstein College of Medicine)
ClassificationRadiation-emitting productsBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlbert Einstein College Of Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlbert Einstein College Of Medicine Inc
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A